{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:29:44Z","timestamp":1791127784720,"version":"4.1.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,30]]},"DOI":"10.7759\/cureus.46290","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T05:11:50Z","timestamp":1696137110000},"source":"Crossref","is-referenced-by-count":8,"title":["Methotrexate-Induced Mucositis: A Consequence of Medication Error in a Rheumatoid Arthritis Patient"],"prefix":"10.7759","author":[{"given":"Rujen","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva K","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Jasraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Fauzdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957.pub2","article-title":"Methotrexate for treating rheumatoid arthritis","volume":"2014","author":"Lopez-Olivo MA","year":"2014","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2014, 2014:10.1002\/14651858.CD000957.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman B","year":"2019","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019, 86:301-7. 10.1016\/j.jbspin.2018.07.004","journal-title":"Joint Bone Spine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoms.2018.06.009","article-title":"Severe stomatitis caused by misuse of methotrexate in an elderly patient with chronic rheumatoid arthritis","volume":"31","author":"Yamada K","year":"2019","unstructured":"Yamada K, Tomihara K, Yamazaki M, Noguchi M. Severe stomatitis caused by misuse of methotrexate in an elderly patient with chronic rheumatoid arthritis. J Oral Maxillofac Surg Med Pathol. 2019, 31:284-7. 10.1016\/j.ajoms.2018.06.009","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(98)80049-8","article-title":"Methotrexate in rheumatoid arthritis: an update with a focus on mechanisms involved in toxicity","volume":"27","author":"van Ede AE","year":"1998","unstructured":"van Ede AE, Laan RF, Blom HJ, De Abreu RA, van de Putte LB. Methotrexate in rheumatoid arthritis: an update with a focus on mechanisms involved in toxicity. Semin Arthritis Rheum. 1998, 27:277-92. 10.1016\/s0049-0172(98)80049-8","journal-title":"Semin Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2012.12.008","article-title":"Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review","volume":"115","author":"Troeltzsch M","year":"2013","unstructured":"Troeltzsch M, von Blohn G, Kriegelstein S, Woodlock T, Gassling V, Berndt R, Troeltzsch M. Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013, 115:28-33. 10.1016\/j.oooo.2012.12.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2010.03.012","article-title":"Oral mucositis","volume":"46","author":"Raber-Durlacher JE","year":"2010","unstructured":"Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010, 46:452-6. 10.1016\/j.oraloncology.2010.03.012","journal-title":"Oral Oncol"},{"key":"ref7","article-title":"Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Brunton L","year":"2013","unstructured":"Brunton L, Hilal-Dandan R, Knollman BC. Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics. McGraw-Hill, New York City, NY; 2013."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008872.pub2","article-title":"Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)","author":"Colebatch AN","year":"2011","unstructured":"Colebatch AN, Marks JL, Edwards CJ. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. 2011, 10.1002\/14651858.CD008872.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.015","article-title":"Low-dose methotrexate-induced skin toxicity: keratinocyte dystrophy as a histologic marker","volume":"73","author":"Delyon J","year":"2015","unstructured":"Delyon J, Ortonne N, Benayoun E, Moroch J, Wolkenstein P, Sbidian E, Chosidow O. Low-dose methotrexate-induced skin toxicity: keratinocyte dystrophy as a histologic marker. J Am Acad Dermatol. 2015, 73:484-90. 10.1016\/j.jaad.2015.06.015","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2040","article-title":"Evaluation, identification, and management of acute methotrexate toxicity in high-dose methotrexate administration in hematologic malignancies","volume":"10","author":"Feinsilber D","year":"2018","unstructured":"Feinsilber D, Leoni RJ, Siripala D, Leuck J, Mears KA. Evaluation, identification, and management of acute methotrexate toxicity in high-dose methotrexate administration in hematologic malignancies. Cureus. 2018, 10:10.7759\/cureus.2040","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1553-7250(08)34091-4","article-title":"The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership","volume":"34","author":"Cousins DD","year":"2008","unstructured":"Cousins DD, Heath WM. The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership. Jt Comm J Qual Patient Saf. 2008, 34:700-2. 10.1016\/s1553-7250(08)34091-4","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard SC","year":"2016","unstructured":"Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and managing toxicities of high-dose methotrexate. Oncologist. 2016, 21:1471-82. 10.1634\/theoncologist.2015-0164","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.181054","article-title":"Low-dose methotrexate toxicity","volume":"191","author":"Pivovarov K","year":"2019","unstructured":"Pivovarov K, Zipursky JS. Low-dose methotrexate toxicity. CMAJ. 2019, 191:10.1503\/cmaj.181054","journal-title":"CMAJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179978-methotrexate-induced-mucositis-a-consequence-of-medication-error-in-a-rheumatoid-arthritis-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:00Z","timestamp":1707509400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179978-methotrexate-induced-mucositis-a-consequence-of-medication-error-in-a-rheumatoid-arthritis-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.46290","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,30]]}}}